Stay updated on PRC-063 vs Lisdexamfetamine in Adult ADHD Driving Clinical Trial
Sign up to get notified when there's something new on the PRC-063 vs Lisdexamfetamine in Adult ADHD Driving Clinical Trial page.

Latest updates to the PRC-063 vs Lisdexamfetamine in Adult ADHD Driving Clinical Trial page
- Check7 days agoChange DetectedA banner announces that NIH is transitioning from the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check14 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2 on the ClinicalTrials.gov 403 error page.SummaryDifference0.2%

- Check21 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changed from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check41 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the expected study content with an access-denied message. The HTML snippet includes the 403 header and a Home link, along with a site revision note, indicating restricted access rather than the usual study details.SummaryDifference17%

- Check62 days agoChange DetectedThe page version changed from v3.6.5 to v3.6.6. This indicates a new published revision of the ClinicalTrials.gov entry rather than changes to the trial details.SummaryDifference0.1%

- Check84 days agoChange DetectedThe page's revision label was updated to v3.6.5, reflecting a new software version for the page.SummaryDifference0.1%

Stay in the know with updates to PRC-063 vs Lisdexamfetamine in Adult ADHD Driving Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PRC-063 vs Lisdexamfetamine in Adult ADHD Driving Clinical Trial page.